Also Read: Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention At CROI 2025, the primary results of a Phase 2 study evaluating lenacapavir (LEN) with teropavimab (TAB) and ...

Across the recent three months, 14 analysts have shared their insights on Gilead Sciences GILD, expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...

Gilead Sciences has declared a quarterly dividend to stockholders on record at the close of business on March 14, 2025. (Reuters) Gilead Sciences, with a market capitalization of $143.8 billion ...

A new study published has revealed that Gilead Sciences’ Lenacapavir has shown promising results as prevention method for HIV with long-lasting effects. The annual injection can be used as a pre ...

Night - Clear. Winds ESE at 7 to 8 mph (11.3 to 12.9 kph). The overnight low will be 47 °F (8.3 °C). Partly cloudy with a high of 75 °F (23.9 °C). Winds from SE to SSE at 7 to 17 mph (11.3 to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...

Seize this rare opportunity to secure a 512 sqm premium homesite in the sought after Figtree Hill by Stockland an exclusive new master planned community in Gilead, NSW. Perfectly positioned ...

What are the GTA 6 map locations? We’re back, baby: Vice City – the playground of the rich and a true cesspit of indulgence is now confirmed to be the location of GTA 6. Not only that but the ...

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 ...